What is Biosensing Instrument?
Biosensing Instrument operates at the intersection of advanced optics and molecular biology, specializing in the development of label-free molecular interaction instruments. The company is best known for its pioneering work in Surface Plasmon Resonance (SPR) technology, which enables researchers to observe binding reactions in real-time. Their flagship SPRm 200 system represents a significant technological leap, effectively merging optical microscopy with SPR to provide unprecedented insights into cellular membrane dynamics. By serving both the pharmaceutical industry and academic research institutions, the company provides essential bioanalytical tools that streamline the drug discovery pipeline. Their diverse product portfolio, which also includes high-performance benchtop instruments, supports a wide array of applications ranging from electrochemical measurements to chemical vapor sensing, establishing the firm as a critical infrastructure provider for modern laboratory environments.
How much funding has Biosensing Instrument raised?
Biosensing Instrument has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Biosensing Instrument
PPP
Public-Private Partnership
What's next for Biosensing Instrument?
With the infusion of this late-stage capital, Biosensing Instrument is poised to scale its operational capacity and expand its global footprint. The strategic focus will likely shift toward enhancing the commercialization of its SPR technology suite and deepening its penetration into the pharmaceutical R&D market. As the demand for high-fidelity, real-time molecular data continues to rise, the company is strategically aligned to capitalize on these industry trends. Future growth initiatives will likely prioritize the refinement of its existing product ecosystem and the potential development of next-generation sensing platforms, ensuring that the firm remains at the forefront of bioanalytical innovation while maintaining its commitment to precision and reliability in scientific research.
See full Biosensing Instrument company page
